Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD160 Expression in Retinal Vessels is Associated With Retinal Neovascular Diseases

NCT03940664 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT03940664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03940664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD160 Expression in Retinal Vessels is Associated With Retinal Neovascular Diseases
Lead sponsor
CHU de Reims
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
July 31, 2017
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

surgical retinal